{"title":"Heavy menstrual bleeding in adolescence: who to investigate and how to manage it","authors":"S. L. Walter, S. Channing, N. S. Crouch","doi":"10.1111/tog.12924","DOIUrl":null,"url":null,"abstract":"\nAdolescent heavy menstrual bleeding (HMB) is commonly related to hypothalamic pituitary ovarian axis immaturity, which improves with age. This article outlines when and how to investigate for underlying pathological causes.\nMedical treatment for adolescent HMB consists predominantly of hormonal contraceptives. Preparation choice depends upon patient preference, comorbidities and co‐existing conditions.\nAcute adolescent HMB is rare; a suggested framework for assessing and managing such cases is provided within this article.\n\nTo understand how to clinically evaluate adolescent HMB.\nTo understand when and how to investigate adolescent HMB.\nTo understand the different medical treatment options for HMB, their efficacy, risks and alternatives.\nTo understand the management of acute adolescent HMB.\n\nDuties of confidentiality must be balanced against safeguarding concerns.\n","PeriodicalId":509656,"journal":{"name":"The Obstetrician & Gynaecologist","volume":"83 16","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Obstetrician & Gynaecologist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/tog.12924","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Adolescent heavy menstrual bleeding (HMB) is commonly related to hypothalamic pituitary ovarian axis immaturity, which improves with age. This article outlines when and how to investigate for underlying pathological causes.
Medical treatment for adolescent HMB consists predominantly of hormonal contraceptives. Preparation choice depends upon patient preference, comorbidities and co‐existing conditions.
Acute adolescent HMB is rare; a suggested framework for assessing and managing such cases is provided within this article.
To understand how to clinically evaluate adolescent HMB.
To understand when and how to investigate adolescent HMB.
To understand the different medical treatment options for HMB, their efficacy, risks and alternatives.
To understand the management of acute adolescent HMB.
Duties of confidentiality must be balanced against safeguarding concerns.